Silvana Chiara
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 12, 2018
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study.
Journal: Journal of geriatric oncology
Published: July 27, 2017
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Journal: British journal of cancer
Published: August 08, 2016
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.
Journal: Cancer medicine
Published: May 04, 2016
Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang.
Journal: Cancer metastasis reviews
Published: March 08, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 23, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 28, 2015
Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity.
Journal: World journal of gastroenterology
Published: March 02, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 21, 2015
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
Journal: The New England journal of medicine
Published: October 23, 2014
Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 18, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026